Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose.
about
Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiationSystems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications.Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.Doxycycline synergizes with doxorubicin to inhibit the proliferation of castration-resistant prostate cancer cells.Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
P2860
Doxycycline and therapeutic targeting of the DNA damage response in cancer cells: old drug, new purpose.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Doxycycline and therapeutic ta ...... cells: old drug, new purpose.
@en
Doxycycline and therapeutic ta ...... cells: old drug, new purpose.
@nl
type
label
Doxycycline and therapeutic ta ...... cells: old drug, new purpose.
@en
Doxycycline and therapeutic ta ...... cells: old drug, new purpose.
@nl
prefLabel
Doxycycline and therapeutic ta ...... cells: old drug, new purpose.
@en
Doxycycline and therapeutic ta ...... cells: old drug, new purpose.
@nl
P2860
P356
P1433
P1476
Doxycycline and therapeutic ta ...... cells: old drug, new purpose.
@en
P2093
Maria Peiris-Pagès
P2860
P304
P356
10.18632/ONCOSCIENCE.215
P577
2015-08-24T00:00:00Z